You are here
Platform technologies for therapeutic and diagnostic applications are available for co-development and/or licensing.
mutREAD is a novel DNA sequencing method that measures the presence of mutational signatures in all types of clinical and biological samples.Read more
Patented technology that allows manipulation of the disulfide bond configuration of the hinge/CH1 regions to control the activity of mAbs directed against a range of immune receptors.Read more
Please see https://medphys.royalsurrey.nhs.uk/omidb for detailed information.Read more